| HOME >> BIOLOGY >> TECHNOLOGY |
Pricing risk remains the key investment concern in cancer. Moreover, the level of scrutiny by payers regarding the cost-effectiveness of cancer treatments has intensified in recent years.
Your key questions answered
* What will be the major growth indications and the accompanying growth drivers in the cancer market over the next 6 years?
* Which were the leading players in the cancer market in 2010?
* Which products will be the future growth drivers for the cancer health market?
* Which therapeutic categories are forecast to have the highest levels of commercial potential over the period 2010–16?
* Which companies are best positioned to succeed in the cancer market over the period 2010–16?
Executive Summary
Overview and epidemiology of women's health
Global market analysis
Pipeline analysis
Competitive landscape
About the author
Disclaimer
Overview and epidemiology of women's health
Summary
Introduction
Osteoporosis
Overview
Diagnosis treatment and management
Epidemiology
Forecast epidemiology
Hormonal contraception
Overview
Diagnosis treatment and management
Epidemiology
Forecast epidemiology
Hormone replacement therapies
Overview
Diagnosis, treatment and management
Infertility treatment
Overview
Diagnosis, treatment and management
Epidemiology
Forecast epidemiology
Global market analysis
Summary
Market analysis by geography
Market analysis by therapy area
Hormonal contraceptives
Osteoporosis
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |